GALECTIN THERAPEUTICS INC.

Codice
GALT
Risorse esterne
Opinione della community
Prezzo Variazione Volume
2.53 +2.85 €
(+-890.62%)
139356
P/E Obiettivo ad 1anno
0 2.75 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 6
Sell : 4

Gian Marco

Commenti


Notizie

Galectin Therapeutics (GALT) Getting Favorable Press Coverage, Report Finds - Sports Perspectives

Galectin Therapeutics (GALT) traded down 3.16% during trading on Tuesday, hitting $2.45. 90,638 shares of the stock traded hands. Galectin Therapeutics has a 52-week low of $0.49 and a 52-week high of $3.68. The stock's market cap is $84.94 million. Leggi

Risk Alert in Option Market: Galectin Therapeutics Inc Implied Price Swing Hits An Extreme High - CML News

In the "Why This Matters" section at the end of this article on Galectin Therapeutics Inc we're going to take a step back and show in great specificity that there is actually a lot less "luck" in successful option trading than many people know. The ...altro » Leggi

Galectin Therapeutics Inc. (GALT) Expected to Announce Earnings of -$0.13 Per Share - Sports Perspectives

Shares of Galectin Therapeutics (GALT) traded up 3.36% during mid-day trading on Tuesday, hitting $2.46. 175,567 shares of the company's stock traded hands. The stock has a 50 day moving average price of $2.55 and a 200-day moving average price of ... Leggi

Galectin Therapeutics Inc (GALT) Seeing Increased Volatility in Session - The Times

Shares of Galectin Therapeutics Inc (GALT) have seen the needle move -1.19% or -0.03 in the most recent session. The NASDAQ listed ... Learning how to trust instinct might be the difference between a good trade and a great trade. Investors who are able ...altro » Leggi

Market Traders Recap -: Galectin Therapeutics, Inc. (GALT) - Hot Stocks Point

Galectin Therapeutics, Inc. (GALT) ended its day with gain 1.28% and finalized at the price of $2.38. During its last trading session, Stock traded with the total exchanged volume of 0.24 million shares. The average volume stands around 0.43 million ...altro » Leggi

Cigna Corporation (CI) is at $169.58 per share and Galectin Therapeutics, Inc. (GALT) is listed at $2.37 - Stocks Gallery

In recent trading day Cigna Corporation (CI) stock showed the move of -0.40% with the closing price of $169.58. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved in the past ...altro » Leggi

Galectin Therapeutics, Inc. (GALT) has a value of $2.45 per share While Hemispherx Biopharma, Inc. (HEB) is stand at ... - Stocks Gallery

In recent trading day Galectin Therapeutics, Inc. (GALT) stock showed the move of -8.24% with the closing price of $2.45. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved in ...altro » Leggi

Generic Drugs Stocks on Investors' Radar -- Catalyst Pharma, Lannett, Evoke Pharma, and Galectin Therapeutics - PR Newswire (press release)

On Tuesday, shares in Norcross, Georgia-based Galectin Therapeutics Inc. recorded a trading volume of 312,987 shares. The stock finished 1.74% higher at $2.34. The Company's shares have advanced 37.65% in the previous three months and 138.82% ...altro » Leggi

9 hedge funds sold their entire positions in Galectin Therapeutics, Inc. (NASDAQ:GALT) - Post Analyst

Multiple company employees have indulged in significant insider trading. Galectin Therapeutics, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director ZUCCONI THEODORE DANIEL has acquired 1,000 ... Leggi

Decision Time: Galectin Therapeutics Inc (NASDAQ:GALT) Stock Technicals Hit Inflection Point - CML News

Decision Time: Galectin Therapeutics Inc (NASDAQ:GALT) now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point. Watch the key moving average levels that we ...altro » Leggi